RE:RE:RE:RE:RE:RE:RE:This game isn’t over $$$Arch Bio Partners is the real deal. They definitely have credibility as Federal government gave them close to $7M grant toward their phase 2 Covid study. They have phase 2 trials going in Turkey, two hospitals in Calgary and one in Fort Lauderdale.
The phase 2 study must have shown positive results as the Turkish Health Authority extended the Phase 2 to dose another 20 patients.
The company has no debt, no outstanding warrants very small float and high insider ownership and no need for further dilution.
I suspect once phase 2 of study is completed and data analyzed and if positive results are seen it may get emergency use authorization and proceed into Phase 3 study with large US University Hospital. The fact Canadian Federal Government provided large $7M grant towards phase 2, I would not be surprised that they provide additional funding for Phase 3.